Posts Tagged diagnostics

K2M Funds Its Focus On The Complex Spine With IPO

Tuesday, May 20th, 2014 | Permalink

The 10-year-old spine firm initiated its initial public offering this month, transforming from the largest private spine device firm to another public player in a highly competitive market. CEO Eric Major K2M’s focus on complex spinal deformities will help distinguish it from the pack.

Link:
K2M Funds Its Focus On The Complex Spine With IPO

Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

Tuesday, April 8th, 2014 | Permalink

A new law makes vast changes to how clinical laboratory tests will be reimbursed by Medicare over the long term. Although the changes ultimately may lead to payment reductions, both test kits makers and laboratories applaud the new provisions. Reimbursement will better reflect the value that lab tests bring to the health care system, they say.

Link:
Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

SYMPLICITY Results Make Life Difficult For Renal Denervation Programs

Wednesday, March 26th, 2014 | Permalink

The big slice of the device industry, from large-cap firms to venture capitalists, with some stake in the renal denervation opportunity are trying to understand the new reality now that Medtronic’s pivotal Symplicity renal denervation device trial missed its endpoint.

See the original article here:
SYMPLICITY Results Make Life Difficult For Renal Denervation Programs

China Hopes To Implement Unique Device Identifier System By Year End

Monday, March 24th, 2014 | Permalink

China has been talking about implementing a UDI system to track distribution of medical devices for years. Former CFDA and U.S. FDA experts now suggest that China plans to implement such as system by year end.

More:
China Hopes To Implement Unique Device Identifier System By Year End

Will Stryker’s MAKO Purchase Bring Disruption To The Ortho Industry?

Wednesday, March 19th, 2014 | Permalink

Stryker’s adoption of MAKO’s RIO (Robotic-arm Interactive Orthopedic) system could give the global medical supplier a competitive edge over other orthopedic implant makers if the company can win converts to robotic surgery by leveraging its own experience in selling capital equipment.

See the original post:
Will Stryker’s MAKO Purchase Bring Disruption To The Ortho Industry?